Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b4108625afe54f96efc893c33911570 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H23-00 |
filingDate |
1995-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03e379b090dd752f6eb842f68e9a26ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86b3547553178d2dcf9c368e47b2da07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dcb18ec3ec63b17d278251163324be6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d73d97f412dd30d50dee907840b5aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5e4a0adeed5d6c28979a242440e2ce0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598cb49cded70acbeb5231ec8b57c681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20bc49a6399348073483d79a2f28abe2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b77e81442e24e279062ce80779d101b6 |
publicationDate |
1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2194558-A1 |
titleOfInvention |
Conjugates made of metal complexes and oligonucleotides |
abstract |
This invention relates to chemically modified oligonucleotide conjugates that contain a complexing agent or complex that is bound by a connecting component to the oligonucleotides. In this case, the oligonucleotides are modified in a way that prevents or at least significantly inhibits the degradation by naturally occurring nucleases. The oligonucleotide radical can bond specifically and with high bonding affinity to target structures and can thus produce a specific therapeutic or diagnostic effect by the bound complexing agent or complex. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10357578-B2 |
priorityDate |
1994-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |